-
Advertorial
-
FOCUS
-
Guide
-
Lifestyle
-
Tech and Vogue
-
TechandScience
-
CHTF Special
-
Nanshan
-
Futian Today
-
Hit Bravo
-
Special Report
-
Junior Journalist Program
-
World Economy
-
Opinion
-
Diversions
-
Hotels
-
Movies
-
People
-
Person of the week
-
Weekend
-
Photo Highlights
-
Currency Focus
-
Kaleidoscope
-
Tech and Science
-
News Picks
-
Yes Teens
-
Budding Writers
-
Fun
-
Campus
-
Glamour
-
News
-
Digital Paper
-
Food drink
-
Majors_Forum
-
Speak Shenzhen
-
Shopping
-
Business_Markets
-
Restaurants
-
Travel
-
Investment
-
Hotels
-
Yearend Review
-
World
-
Sports
-
Entertainment
-
QINGDAO TODAY
-
In depth
-
Leisure Highlights
-
Markets
-
Business
-
Culture
-
China
-
Shenzhen
-
Important news
在线翻译:
szdaily -> China -> 
President Xi orders probe into vaccine scandal
    2018-07-24  08:53    Shenzhen Daily

(From P1)

The State Drug Administration will conduct unannounced inspections on all companies that produce vaccines.

According to the Center for Disease Control and Prevention in Shandong, the 252,600 doses of substandard DTaP vaccine sold by Changchun Changsheng Bio-tech were distributed to Jinan, Zibo, Yantai, Jining, Tai’an, Weihai, Rizhao and Laiwu in Shandong. A total of 215,184 children were injected with the substandard vaccine.

In Hebei, 143,941 children in Shijiazhuang, Langfang and Dingzhou were given substandard DTaP vaccine produced by Wuhan Institute of Biological Products Co. Ltd., said the Center for Disease Control and Prevention in Hebei.

Some substandard DTaP vaccines produced by Wuhan Institute of Biological Products Co. Ltd. were also distributed to Chongqing, but the Center for Disease Control and Prevention in Chongqing has not yet provided details.

The Centers for Disease Control and Prevention in Shandong, Hebei and Chongqing said they would vaccinate those affected again.

China’s drug regulator said Sunday that it has ordered Changchun Changsheng Life Sciences Ltd. to stop production and launched an investigation into the company over illegal production of rabies vaccines for human use.

An official with China Food and Drug Administration (CFDA) said it found that the company had fabricated production records and product inspection records, arbitrarily changed process parameters and equipment during its production of freeze-dried human rabies vaccines.

The CFDA had revoked the company’s drug GMP certificate following its serious violations of relevant law and regulations, and demanded a recall of unused vaccines, according to the official.

Changsheng, a listed company at Shenzhen Stock Exchange, has also been put under investigation by China Securities Regulatory Commission for law violations and irregularities in information disclosure, the commission said yesterday. The company said in a statement that it faces risks of being delisted.

Changsheng shares, which resumed trading yesterday afternoon session after being suspended in the morning, were down 10 percent. They have slumped 47 percent since mid-July. (Xinhua)

(Related story on P10)

深圳报业集团版权所有, 未经授权禁止复制; Copyright 2010, All Rights Reserved.
Shenzhen Daily E-mail:szdaily@szszd.com.cn